Crinetics Pharmaceuticals Strengthens Leadership With New Appointment

TipRanksDec 17 05:55

Crinetics Pharmaceuticals Analyst Ratings

BenzingaDec 16 22:46 · Ratings

Neurocrine's Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential

Analyst UpgradesDec 16 22:10

Express News | Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer

BreakingsDec 16 21:00

Press Release: Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer

Dow JonesDec 16 21:00

JMP Securities Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $87

Futu NewsDec 16 13:32 · Ratings